Pacer Advisors, Inc. Dynavax Technologies Corp Transaction History

Pacer Advisors, Inc.

$33.6 Billion
Q3 2025

A detailed history of Pacer Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 322,119 shares of DVAX stock, worth $3.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

322,119

Previous 8,613 3639.92%

Holding current value

$3.16 Million

Previous $85,000 3662.35%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$9.36 - $11.36 $2.93 Million - $3.56 Million	313,506 Added 3639.92%	322,119 $3.2 Million
Q2 2025 Aug 12, 2025	SELL	$9.4 - $12.87 $130,895 - $179,214	-13,925 Reduced 61.78%	8,613 $85,000
Q1 2025 May 06, 2025	BUY	$12.39 - $14.4 $279,245 - $324,547	22,538 New	22,538 $292,000
Q3 2024 Nov 12, 2024	BUY	$10.05 - $11.61 $16,884 - $19,504	1,680 Added 28.91%	7,491 $83,000
Q2 2024 Aug 13, 2024	SELL	$10.73 - $12.58 $27.9 Million - $32.7 Million	-2,596,435 Reduced 99.78%	5,811 $65,000
Q1 2024 May 10, 2024	BUY	$11.7 - $14.98 $30.4 Million - $39 Million	2,602,246 New	2,602,246 $32.3 Million
Q4 2022 Feb 06, 2023	BUY	$10.27 - $13.29 $2.53 Million - $3.28 Million	246,619 Added 37.66%	901,476 $9.59 Million
Q3 2022 Oct 18, 2022	SELL	$9.93 - $17.44 $2.52 Million - $4.43 Million	-254,162 Reduced 27.96%	654,857 $6.84 Million
Q2 2022 Aug 12, 2022	BUY	$7.45 - $12.83 $6.77 Million - $11.7 Million	909,019 New	909,019 $11.4 Million
Q2 2021 Jul 21, 2021	SELL	$7.25 - $10.99 $58,964 - $89,381	-8,133 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$4.57 - $11.18 $48,633 - $118,977	-10,642 Reduced 56.68%	8,133 $80,000
Q4 2020 Jan 20, 2021	BUY	$3.73 - $5.6 $45,901 - $68,913	12,306 Added 190.23%	18,775 $84,000
Q3 2020 Oct 19, 2020	BUY	$4.32 - $11.7 $27,946 - $75,687	6,469 New	6,469 $28,000
Q4 2018 Feb 13, 2019	SELL	$8.14 - $13.28 $86,479 - $141,086	-10,624 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $125,894 - $169,984	10,624 New	10,624 $132,000
Q1 2018 May 14, 2018	SELL	$14.65 - $19.9 $42,851 - $58,207	-2,925 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $50,602 - $70,434	2,925	2,925 $55,000

Others Institutions Holding DVAX

# of Institutions

294

Shares Held

121M

Call Options Held

294K

Put Options Held

77.6K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.24B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Dynavax Technologies Corp Transaction History